{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:25:57Z","timestamp":1794471957042,"version":"4.9.1"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T00:00:00Z","timestamp":1389139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0084985","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T17:05:14Z","timestamp":1389200714000},"page":"e84985","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["Increased Risk for Developing Major Adverse Cardiovascular Events in Stented Chinese Patients Treated with Dual Antiplatelet Therapy after Concomitant Use of the Proton Pump Inhibitor"],"prefix":"10.1371","volume":"9","author":[{"given":"Jian-Jun","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Ying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Mei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Wei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Guang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,1,8]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"e426","DOI":"10.1161\/CIR.0b013e318212bb8b","article-title":"2011 ACCF\/AHA focused update incorporated into the ACC\/AHA 2007 guidelines for the management of patients with unstable angina\/non-ST-elevation myocardial infarction, a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"123","author":"JL Anderson","year":"2011","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"11069","DOI":"10.1073\/pnas.0510446103","article-title":"The active metabolite of clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts","volume":"103","author":"P Savi","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/clpt.2008.20","article-title":"The effect of CYP2C19 polymorphism on the pharmacokinetics and pharmacodynamics of clopidogrel, a possible mechanism for clopidogrel resistance","volume":"84","author":"KA Kim","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMoa0808227","article-title":"Genetic determinants of response to clopidogrel and cardiovascular events","volume":"360","author":"T Simon","year":"2009","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMoa0809171","article-title":"Cytochrome p-450 polymorphisms and response to clopidogrel","volume":"360","author":"JL Mega","year":"2009","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.jacc.2008.08.002","article-title":"ACCF \/ ACG\/ AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use, a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents","volume":"52","author":"DL Bhatt","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1345\/aph.1G703","article-title":"Acid suppressive therapy use on an inpatient internal medicine service","volume":"40","author":"CQ Pham","year":"2006","journal-title":"Ann Pharmacother"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/dmd.32.8.821","article-title":"Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities","volume":"32","author":"XQ Li","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Lim PW, Goh KL, Wong BC (2005) CYP2C19 genotype and the PPIs\u2013focus on rabeprazole. J Gastroenterol Hepatol 20 (suppl): s22\u201328.","DOI":"10.1111\/j.1440-1746.2005.04167.x"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/0091270008315310","article-title":"Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel","volume":"48","author":"DS Small","year":"2008","journal-title":"J Clin Pharmacol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1161\/CIRCINTERVENTIONS.110.957829","article-title":"Pharmacodynamic effects of concomitant versus staggered clopidogrel and omeprazole intake, results of a prospective randomized crossover study","volume":"3","author":"JL Ferreiro","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/clpt.2010.219","article-title":"Differential effects of omeprazole and pantoprazole on the pharmacodynamics and pharmacokinetics of clopidogrel in healthy subjects, randomized, placebo-controlled, crossover comparison studies","volume":"89","author":"DJ Angiolillo","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/jama.2009.261","article-title":"Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome","volume":"301","author":"PM Ho","year":"2009","journal-title":"JAMA"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.amjcard.2010.01.348","article-title":"Risk of adverse outcomes in Taiwan associated with concomitant use of clopidogrel and proton pump inhibitors in patients who received percutaneous coronary intervention","volume":"105","author":"CC Huang","year":"2010","journal-title":"Am J Cardiol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/archinternmed.2010.34","article-title":"Risk of rehospitalization for patients using clopidogrel with a proton pump inhibitor","volume":"170","author":"KM Stockl","year":"2010","journal-title":"Arch Intern Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"378","DOI":"10.7326\/0003-4819-153-6-201009210-00005","article-title":"Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use","volume":"153","author":"M Charlot","year":"2010","journal-title":"Ann Intern Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0140-6736(09)61525-7","article-title":"Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor, an analysis of two randomised trials","volume":"374","author":"ML O\u2019Donoghue","year":"2009","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"337","DOI":"10.7326\/0003-4819-152-6-201003160-00003","article-title":"Outcomes with concurrent use of clopidogrel and proton-pump inhibitors","volume":"152","author":"WA Ray","year":"2010","journal-title":"Ann Intern Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1161\/CIRCULATIONAHA.109.873497","article-title":"Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome","volume":"120","author":"JA Rassen","year":"2009","journal-title":"Circulation"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.pharmthera.2010.10.001","article-title":"Individual variability in the disposition of and response to clopidogrel: Pharmacogenomics and beyond","volume":"129","author":"HG Xie","year":"2011","journal-title":"Pharmacol Ther"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1146\/annurev.pharmtox.41.1.815","article-title":"Molecular basis of ethnic differences in drug metabolism and response","volume":"41","author":"HG Xie","year":"2001","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1056\/NEJMoa067731","article-title":"Stent thrombosis in randomized clinical trials of drug-eluting stents","volume":"356","author":"L Mauri","year":"2007","journal-title":"N Engl J Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.jacc.2010.10.023","article-title":"A Randomized Clinical Study Comparing Double Kissing Crush With Provisional Stenting for Treatment of Coronary Bifurcation Lesions","volume":"57","author":"SL Chen","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials, a case for standardized definitions","volume":"115","author":"DE Cutlip","year":"2007","journal-title":"Circulation"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jacc.2007.06.064","article-title":"Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin, the randomized, double-blind OCLA (omeprazole clopidogrel aspirin) study","volume":"51","author":"M Gilard","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"ref26","first-page":"e1","article-title":"Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel","volume":"157","author":"JM Siller-Matula","year":"2009","journal-title":"Am Heart J"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.thromres.2009.08.016","article-title":"Effect of comedication with proton pump inhibitors (PPIs) on post-interventional residual platelet aggregation in patients undergoing coronary stenting treated by dual antiplatelet therapy","volume":"125","author":"CS Zuern","year":"2010","journal-title":"Thromb Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-2125.2010.03717.x","article-title":"Influences of different proton pump inhibitors on the antiplatelet function of clopidogrel in relation to CYP2c19 genotypes","volume":"70","author":"T Furuta","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1007964","article-title":"Clopidogrel with or without omeprazole in coronary artery disease","volume":"363","author":"DL Bhatt","year":"2010","journal-title":"N Engl J Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jacc.2008.05.053","article-title":"Initial assessment of a drug interaction between clopidogrel and proton pump inhibitors","volume":"52","author":"E Pezalla","year":"2008","journal-title":"J Am Coll Cardiol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0084985","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T02:52:35Z","timestamp":1588992755000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0084985"}},"subtitle":[],"editor":[{"given":"German E.","family":"Gonzalez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,1,8]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0084985","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0084985.g001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0084985.t001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0084985.t002","asserted-by":"subject"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,8]]}}}